Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol
Oral and transdermal glutathione are being developed to restore levels in autistic children
If a patient asks for just Ipamorelin, most clinicians will recommend adding CJC-1295 to get meaningful results
Clinical Pharmacology & Therapeutics 2022: volume 111, issue 5, pages 1,0071,021
Where water is required for preparing or diluting medications for use in neonates, only preservative-free Sterile Water for Injection should be used
